Consistent in vitro activity of sulbactam-durlobactam against genetically diverse carbapenem-resistant Acinetobacter baumannii in a high-endemic Brazilian setting
Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)
DOI: 10.1128/aac.00109-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Gabriela da Silva Collar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Pesquisa em Bacteriologia Clínica, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Sulbactam, Carbapenems, Anti-Bacterial Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegre.
Abstract (Originalsprache)
Carbapenem-resistant Acinetobacter baumannii (CRAb) causes high-mortality infections, with limited treatment options. We evaluated sulbactam-durlobactam activity against 94 isolates from Brazil. Durlobactam markedly reduced sulbactam MICs, restoring susceptibility in all CRAb. They belonged to seven STs, mainly ST730 and ST79. Despite genetic and phenotypic diversity, including distinct carbapenemase genes (particularly bla OXA-23-like ) and the presence of PBP3 mutations, activity remained consistent. These findings support sulbactam-durlobactam as an effective option against CRAb in this high-endemic setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Pesquisa em Bacteriologia Clínica, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Laboratório Central do Hospital Nossa Senhora da Conceição, Grupo Hospitalar Conceição, Porto Alegre, Brazil.
- Laboratório de Pesquisa em Resistência Antimicrobiana, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
- Serviço de Diagnóstico Laboratorial, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
- Programa de Pós-graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
ORCID-Profile: Gabriela da Silva Collar, Mariana Preussler Mott, Afonso Luís Barth, Juliana Caierão
Förderung
- Instituto Nacional de Pesquisa em Resistência Bacteriana
- Hospital de Clínicas de Porto Alegre
Zitieren
APA
Collar, G. S., Dornelles, L. S., Salvador, J. C., Pinto, J. B., Pereira, D. C., Barth, P. O., Cardoso, J. V. B., Matos, W. L., Mott, M. P., Barth, A. L., Martins, A. F., & Caierão, J. (2026). Consistent in vitro activity of sulbactam-durlobactam against genetically diverse carbapenem-resistant Acinetobacter baumannii in a high-endemic Brazilian setting. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.00109-26
Vancouver
Collar GS, Dornelles LS, Salvador JC, Pinto JB, Pereira DC, Barth PO, et al. Consistent in vitro activity of sulbactam-durlobactam against genetically diverse carbapenem-resistant Acinetobacter baumannii in a high-endemic Brazilian setting. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.00109-26
BibTeX
@article{Collar2026,
author = {Collar, Gabriela da Silva and Dornelles, Luana Silva and Salvador, Júlia Cover and Pinto, Jaqueline Becker and Pereira, Dariane Castro and Barth, Patrícia Orlandi and Cardoso, João Vitor Barboza and Matos, William Latosinski and Mott, Mariana Preussler and Barth, Afonso Luís and Martins, Andreza Francisco and Caierão, Juliana},
title = {Consistent in vitro activity of sulbactam-durlobactam against genetically diverse carbapenem-resistant Acinetobacter baumannii in a high-endemic Brazilian setting},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {7},
doi = {10.1128/aac.00109-26}
}
EUVIMED